Evidence map›Paper›PMID 37035106›Full record

Observational studyTransplant international : official journal of the European Society for Organ Transplantation2023

Management and Outcome After Early Renal Transplant Vein Thrombosis: A French Multicentre Observational Study of Real-Life Practice Over 24 Years.

Ludivine Cambou, Clémentine Millet, Nicolas Terrier, Paolo Malvezzi, Marc-Olivier Timsit, Dany Anglicheau, Lionel Badet, Emmanuel Morelon, Thomas Prudhomme, Nassim Kamar and 7 more

Open access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Transplant international : official journal of the European Society for Organ Transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Venous Thromboembolism in Unusual Locations.The Medical clinics of North America · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

Ludivine CambouClermont-Ferrand University Hospital, Department of Urology, Clermont-Ferrand, France.
Clémentine MilletClermont-Ferrand University Hospital, Department of Urology, Clermont-Ferrand, France.
Nicolas TerrierService d'Urologie, CHU Grenoble-Alpes, Grenoble, France.
Paolo MalvezziService de Néphrologie, Hémodialyse, Aphérèses et Transplantation Rénale, CHU Grenoble-Alpes, Grenoble, France.
Marc-Olivier TimsitNecker Hospital, Assistance Publique-Hôpitaux de Paris, Department of Urology, Paris, France.
Dany AnglicheauNecker Hospital, Assistance Publique-Hôpitaux de Paris, Department of Nephrology and Kidney Transplantation, Paris, France.
Lionel BadetService d'Urologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
Emmanuel MorelonService de Néphrologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
Thomas PrudhommeToulouse University Hospital, Department of Urology, Toulouse, France.
Nassim KamarToulouse University Hospital, Department of Nephrology, Toulouse, France.
Anne LejayDepartment of Vascular Surgery and Kidney Transplantation, University of Strasbourg, Strasbourg, France.
Peggy PerrinDepartment of Nephrology and Transplantation, University Hospital, Strasbourg, France.
Charlotte Uro-CosteClermont-Ferrand University Hospital, Department of Nephrology, 3iHP, Clermont-Ferrand, France.
Bruno PereiraClermont-Ferrand University Hospital, Biostatistics Unit (DRCI), Clermont-Ferrand, France.
Anne Elisabeth HengClermont-Ferrand University Hospital, Department of Nephrology, 3iHP, Clermont-Ferrand, France.
Cyril GarrousteClermont-Ferrand University Hospital, Department of Nephrology, 3iHP, Clermont-Ferrand, France.
Laurent GuyClermont-Ferrand University Hospital, Department of Urology, Clermont-Ferrand, France.
University of Clermont Auvergne · FRHôpital Necker-Enfants Malades · FRMetabolism and Renal Physiology · FRUniversité de Strasbourg · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Grenoble · FRHôpital Edouard Herriot · FRHospices Civils de Lyon · FRToulouse Mathematics Institute · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early (<14 days) renal transplant vein thrombosis posttransplant (eRVTPT) is a rare but threatening complication. We aimed to assess eRVTPT management and the rate of functional renal transplantation. Of 11,172 adult patients who had undergone transplantation between 01/1997 and 12/2020 at 6 French centres, we identified 176 patients with eRVTPT (1.6%): 16 intraoperative (Group 1, G1) and 160 postoperative (Group 2, G2). All but one patient received surgical management. Patients in group G2 had at least one imaging test for diagnostic confirmation (N = 157, 98%). During the operative management of the G2 group, transplantectomy for graft necrosis was performed immediately in 59.1% of cases. In both groups, either of two techniques was preferred, namely, thrombectomy by renal venotomy or thrombectomy + venous anastomosis repair, with no difference in the functional graft rate (FGR) at hospital discharge (

Indexed as

Kidney DiseasesKidney TransplantationVenous ThrombosisAdultHumansKidneyRetrospective StudiesThrombectomyearly vein thrombosiskidney transplantmanagementoutcomevein thrombosis

Identifiers

PMID37035106
PMCPMC10077970
OpenAlexW4360611207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.